Revvity | PKI - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Agilent USD 25M 0 2026-03
Align Technology USD 16.04M 14.04M 2025-12
Bio Techne USD 2.17M 9K 2025-12
Bio-Rad Laboratories USD 12.1M 200K 2025-12
Bruker USD 8.1M 11.9M 2025-12
Celltrion KRW 19B 1.96B 2025-06
Charles River Laboratories USD 26.74M 2.97M 2026-03
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Danaher USD 63M 8M 2026-03
Dentsply International USD 24M 2M 2026-03
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-03
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Illumina USD 26M 1000K 2025-12
Intuitive Surgical USD 20.11B 58.39B 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Laboratory Of America USD 55.1M 100K 2026-03
Medical Developments International AUD 18K 3K 2025-06
Mesa Laboratories USD 3.02M 180K 2024-09
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
OraSure Technologies 1.67M 1.13M 2025-12
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.14M 1.92M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.58M 83K 2026-03
Revvity USD 24.72M 1.2M 2026-03
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Thermo Fisher Scientific USD 354M 11M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Waters USD 42M 33.38M 2026-03
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06